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ABSTRACT 
BACKGROUND: Metal ion release is common following total hip arthroplasty, yet 
postoperative levels have not been defined for most stems currently used in 
clinical practice. 
AIM: To assess metal ion release in the serum of patients with well functioning 
unilateral Exeter V40 primary total hip arthroplasties one year after surgery. 
METHODS: Whole blood chromium and serum cobalt levels were measured in 
20 patients following primary total hip arthroplasty with the Exeter V40 stem and 
a variety of acetabular components one year after surgery.  
RESULTS: Whole blood chromium levels were within the normal range (10-100 
nmol/L), with a single mild elevation of serum cobalt (normal < 20 nmol/L). 
CONCLUSION: In well functioning primary unilateral total hip arthroplasty using 
the Exeter V40 stem with a variety of acetabular components one year post 
surgery, whole blood chromium levels are normal and serum cobalt elevations 
are rare and mild. 
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INTRODUCTION 
 The release of metal ions following the implantation of a metallic device 
has been a well recognized phenomenon in orthopaedics for over fifty years now. 
(1-3) Various studies have shown raised levels of metal ions including titanium, 
nickel, cobalt and chromium in serum, blood clot and urine samples after 
implantation with alloys containing these metals. (4-6) Furthermore, a range of 
prosthetic devices have been implicated, including intramedullary nails and more 
commonly acetabular shells, femoral stems and femoral heads used in total hip 
arthroplasty. (6, 7) 
In recent times, many studies have focused on metal ion release after total 
hip arthroplasty/resurfacing using metal on metal bearings, finding significantly 
elevated levels of cobalt and chromium. (7-11) However, metal ion release is not 
isolated to metal on metal bearings alone, with studies also showing elevated ion 
levels in conventional metal on polyethylene bearings as well, although to a much 
lesser extent. (4, 12-15) Various reasons have been provided explaining these 
elevated levels, with causes such as loosening and taper wear at either the neck-
stem or head-neck interface being implicated. (12, 16-18)  
There is as yet no accepted definition as to the so-called “normal” levels of 
metal ions following conventional total hip arthroplasty. Much variation exists in 
the timing, methods of testing used to detect metal ions levels and the types of 
prosthesis/fixation method involved. However, there is a consensus that the 
blood cobalt and chromium levels of patients with well-functioning metal on metal 
implants are approximately 34 nmol/L and 38.5 nmol/L, respectively. [19] The 
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expert advisory group of the Medicine and Healthcare Products Regulatory 
Agency (UK) has recommended monitoring of patients with metal ion levels 
greater than 119 nmol/L for cobalt and 134.5 nmol/L for chromium. [20] Adverse 
local tissue reactions have been correlated with mean serum cobalt levels of 162 
nmol/L while pseudotumour formation has been reported at mean serum cobalt 
levels of 50.75 nmol/L. [16,18]   
The Exeter V40 System (Stryker Orthopedics, Mahwah, NJ) which utilizes 
a modular design with separate femoral head and femoral stem components is 
currently the most commonly used cemented femoral system for total hip 
arthroplasty in Australia. (19) There are currently no studies that have examined 
metal ion release following the use of the Exeter V40 System for total hip 
arthroplasty. This study aimed to assess metal ion release in the serum of 
patients with well functioning unilateral Exeter V40 primary total hip arthroplasties 
one year after surgery to determine if metal ions are elevated. 
MATERIALS AND METHODS 
Patients for this study were recruited over a 10-month period from 
November 2011 until August 2012. Institutional review board approval was 
obtained. The recruitment was performed at routine one-year postoperative 
outpatient reviews. The inclusion criteria for this study were (1) one year post 
primary unilateral Exeter V40 total hip replacement (cemented femoral 
component with cemented or uncemented acetabular component), (2) no 
prosthesis or metalwork elsewhere, (3) Harris Hip Score > 80 and no 
signs/symptoms of infection, (4) no radiographical signs of loosening, (5) no 
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significant systemic diseases affecting metal metabolism (including chronic renal 
failure with eGFR < 30) and (6) no chronic exposure to metal ions (eg 
occupational). The aim of this study was not to make comparisons between 
groups thus a control group was not selected, and power calculations were not 
performed. An initial sample size of 20 patients was set. 
 All surgeries were performed by one of the two senior authors (RC, HE) at 
two separate institutions. The Exeter V40 femoral components inserted in all 
patients utilized an identical stainless steel alloy (Orthinox Stainless Steel – 
Chromium 19.5-22%, Nickel 9-11%, Manganese 2-4.25%, Molybdenum 2-3%, 
Niobium 0.25-0.8%, Silicon 0.75%, Copper 0.25%, Phosphorus 0.025%, Sulphur 
0.01%, Iron for balance) for both the stem and head components. A modern 
cementing technique was the method of fixation in all cases. No limit on head 
size was defined, with the choice based on intraoperative factors such as stability 
and patient age. 
The choice of acetabular component was based on surgeon preference. 
Thus, a range of components were used including the Exeter X3 Rimfit Cup 
(Stryker Orthopedics, Mahwah, NJ) in cemented fixation and the Fixa (Adler 
Ortho, Cormano, MI), Procotyl (Wright Medical Technology, Arlington, TN) and 
Trident (Stryker Orthopedics, Mahwah, NJ) components in uncemented fixation, 
all made from a titanium alloy (Ti6Al4V – Aluminum 5.5-6.5%, Vanadium 3.5-
4.5%, Titanium for balance). Highly cross-linked ultra-high molecular weight 
polyethylene was used as the acetabular bearing surface in all cases. 
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Blood samples were tested for cobalt and chromium levels by Sullivan 
Nicolaides Pathology, Queensland. Samples were collected from patients into 
EDTA trace element vacutainers (Becton Dickinson, Franklin Lakes, NJ) using a 
stainless steel needle at a collection centre and transported to the laboratory at 
ambient temperature for analysis. Whole blood chromium was analysed first and 
plasma cobalt performed afterwards. Samples were diluted 1 in 20 with diluent 
and distilled water using a Starlet Robot (Hamilton Robotics, Reno, NV) by 
directly sampling from the barcoded EDTA trace element tube after thorough 
mixing. The diluted samples were vortexed and transferred to an Agilent 7500CE 
inductively coupled plasma mass spectrometer (ICPMS) equipped with Octopole 
reaction cells (Agilent Technologies, Santa Clara, CA) for analysis. Helium gas 
was used in the reaction cell for both chromium and cobalt analysis to reduce 
interference from polyatomic species formed in the plasma. The ICPMS counts 
for each analyte were processed using the Agilent 7500CE software. A 
calibration graph was constructed using the counts obtained from the ICPMS 
expressed as a ratio to the internal standard counts for each analytical run and 
specimen type. Quality control samples were run every 20 samples and their 
acceptability was checked. The patient sample results were calculated from the 
calibration graphs, and downloaded to the laboratory computer for authorization. 
Sullivan Nicolaides Pathology defined levels of <20 nmol/L for cobalt and 10-100 
nmol/L for chromium as normal for an Australian population using the method of 
testing mentioned above. These “normal” levels are similar to the levels detected 
in the control and preoperative groups of other studies. (4, 5, 7, 8, 12, 13) 
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RESULTS 
The final group of 20 patients consisted of 9 hybrid (4 Fixa (Adler Ortho, 
Cormano, MI); 4 Procotyl (Wright Medical Technology, Arlington TN); 1 Trident 
(Stryker Orthopedics, Mahwah, NJ) and 11 cemented (Exeter X3 Rimfit (Stryker 
Orthopedics, Mahwah, NJ)) total hip arthroplasties. There were 5 28mm, 8 32mm 
and 7 36mm heads used. Table 1 demonstrates the basic demographics, 
operative details and cobalt/chromium levels for all patients. The mean age at 
surgery was 70.6 years (SD 10.5) and the mean time of follow-up was 13.6 
months (SD 1.4, range 11-17). The only abnormal result has been highlighted in 
bold. This slightly elevated result was not investigated further but the patient will 
continue to be followed up. 
DISCUSSION 
 The results of this study show that at one year in well functioning primary 
unilateral total hip arthroplasty patients with an Exeter V40 stem and a variety of 
acetabular components, whole blood chromium levels are within the normal 
range. Mild elevation of serum cobalt was only seen in one case. 
The metal ion levels found in this study are reassuringly low compared to 
a number of other studies that have been performed assessing metal ion release 
following hip arthroplasty surgery. The majority of these studies focus on metal 
on metal joint arthroplasty/resurfacing procedures, with metal on polyethylene 
bearings acting as a control. (7-11, 13-15) Only a few studies have concentrated 
on metal ion release following conventional metal on polyethylene total hip 
arthroplasty alone. Bartolozzi et al analysed serum and urine chromium levels in 
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the early (<30 days) postoperative period after cemented total hip arthroplasty, 
finding elevated levels in both samples types. An older femoral prosthesis was 
used in this study though, and the exact metal composition of the alloy used was 
not discussed. (4) Jacobs et al analysed serum and urine chromium 
concentrations, as well as serum cobalt, titanium and vanadium over a longer 
period (36 months), finding elevated levels throughout. (12) However, most 
patients in their study underwent uncemented femoral stem fixation and alloy 
metal composition was once again not discussed. Other related studies have 
assessed metal ions other than cobalt and chromium, such as titanium, 
aluminum and vanadium, almost consistently finding elevated levels. (12, 15, 20) 
The mild elevation in serum cobalt found in one patient is unlikely to be 
related to the prostheses that were inserted, considering none of the alloys used 
contained any cobalt. A more likely explanation is the fact that cobalt is absorbed 
primarily via the gastrointestinal system, and thus various dietary factors can act 
to cause minor variations in serum cobalt levels, such as the one seen in this 
single patient. (21, 22) 
The effect of chromium and cobalt ions on the human body is still under 
investigation. Nevertheless, hypersensitivity reactions, local soft tissue toxicity, 
bone loss, cardiac, endocrine and neurological symptoms have all been 
attributed to elevated levels of cobalt and chromium after total hip arthroplasty. 
(16, 18, 23) There is also evidence of harmful consequences from other fields, 
with reports of cardiomyopathy due to cobalt exposure in alcoholic cobaltism and 
industrial poisoning. (24) Although, the exact level and duration of metal ion 
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exposure required for a pathologic response is still difficult to determine, as well 
as the exact nature of this response, and further research needs to be 
undertaken to clarify this link further. (25) 
This study concentrated on a single prosthesis of interest in order to 
minimise confounding factors where others have reported on several prostheses. 
(7, 10, 14, 15, 26) The aim of this study was not to make a comparison, but to 
provide a baseline to define so called “normal” levels in this specific population, 
which has not been previously investigated. The single time point for collection 
(one year postoperative) may arguably be a weakness of this study, but previous 
research has shown that steady state levels of metal ions are reached at 
approximately one year postoperative. (7, 8) 
CONCLUSION 
The results of this study show that in well functioning primary unilateral 
total hip arthroplasty using the Exeter V40 stem with a variety of acetabular 
components, at one year post surgery, whole blood chromium levels are within 
the normal range. Elevation of serum cobalt is rare, and if present, levels are only 
slightly elevated. These levels are reassuring considering the widespread use of 
the Exeter V40 System.  
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Table 1: Basic demographics, operative details and cobalt/chromium levels for all 
patients. 
 
Patient 
 
Age 
 
Time from Surgery 
(months) 
Cobalt 
(nmol/L) 
Chromium 
(nmol/L) 
Head Size 
(mm) 
Acetabular 
Component 
1 83 15 <2 <10L 32 Stryker X3 Rimfit 
2 74 13 3 <10L 32 Stryker X3 Rimfit 
3 64 14 <2 <10L 32 Stryker X3 Rimfit 
4 66 12 4 10 28 Stryker X3 Rimfit 
5 76 15 <2 14 32 Stryker X3 Rimfit 
6 71 12 <2 <10L 32 Stryker X3 Rimfit 
7 75 15 27 <10L 28 Stryker X3 Rimfit 
8 72 15 7 <10L 32 Stryker X3 Rimfit 
9 56 17 3 <10L 28 Stryker X3 Rimfit 
10 61 13 5 <10L 28 Stryker X3 Rimfit 
11 53 14 <2 <10L 28 Stryker X3 Rimfit 
12 73 11 5 29 36 Adler Fixa 
13 66 12 <2 <10L 36 Adler Fixa 
14 75 13 4 <10L 36 Adler Fixa 
15 90 14 6 <10L 32 Adler Fixa 
16 54 13 2 <10L 36 Wright Procotyl 
17 77 12 3 <10L 36 Wright Procotyl 
18 82 14 3 <10L 36 Wright Procotyl 
19 85 14 3 <10L 36 Wright Procotyl 
20 59 13 4 <10L 32 Stryker Trident 
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